StockData
DexCom Inc logo

DexCom Inc (DXCM) stock

DXCMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 22/3033% below fair value
$79.32−0.87 (-1.08%)

Close on Nov 20, 2026Market cap $29.58BP/E 31.2Yield –

DexCom shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

DexCom's shares outstanding was 384M at Sep 30, 2026. For fiscal 2025 it was 406M, down 1.7% from the year before. Over ten years it grew 2.4% a year on average. The highest annual figure on record is 429M in fiscal 2021.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025406M-1.7%
FY2024Dec 31, 2024413M-3.0%
FY2023Dec 31, 2023426M-0.5%
FY2022Dec 31, 2022428M-0.3%
FY2021Dec 31, 2021429M+2.0%
FY2020Dec 31, 2020420M+13.9%
FY2019Dec 31, 2019369M+4.6%
FY2018Dec 31, 2018353M+2.2%
FY2017Dec 31, 2017345M+3.2%
FY2016Dec 31, 2016334M+4.8%
FY2015Dec 31, 2015319M+6.1%
FY2014Dec 31, 2014301M+5.8%
FY2013Dec 31, 2013284M+3.5%
FY2012Dec 31, 2012275M+4.7%
FY2011Dec 31, 2011262M+15.3%
FY2010Dec 31, 2010228M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026384M-5.9%
Q2 FY2026Jun 30, 2026390M-4.4%
Q1 FY2026Mar 31, 2026394M-3.4%
Q4 FY2025Dec 31, 2025399M-1.9%
Q3 FY2025Sep 30, 2025407M-0.7%
Q2 FY2025Jun 30, 2025408M-2.1%
Q1 FY2025Mar 31, 2025408M-2.2%
Q4 FY2024Dec 31, 2024407M-2.5%
Q3 FY2024Sep 30, 2024410M-3.9%
Q2 FY2024Jun 30, 2024417M-3.4%
Q1 FY2024Mar 31, 2024417M-0.4%
Q4 FY2023Dec 31, 2023417M-2.1%
Q3 FY2023Sep 30, 2023427M+0.2%
Q2 FY2023Jun 30, 2023432M+2.4%
Q1 FY2023Mar 31, 2023419M-2.4%
Q4 FY2022Dec 31, 2022426M-1.3%
Q3 FY2022Sep 30, 2022426M-1.0%
Q2 FY2022Jun 30, 2022421M-1.3%
Q1 FY2022Mar 31, 2022429M+2.5%
Q4 FY2021Dec 31, 2021432M-16.8%
Q3 FY2021Sep 30, 2021430M+8.1%
Q2 FY2021Jun 30, 2021427M+10.1%
Q1 FY2021Mar 31, 2021418M+11.2%
Q4 FY2020Dec 31, 2020519M+40.1%
Q3 FY2020Sep 30, 2020398M+7.6%
Q2 FY2020Jun 30, 2020388M+6.5%
Q1 FY2020Mar 31, 2020376M+4.2%
Q4 FY2019Dec 31, 2019370M+9.1%
Q3 FY2019Sep 30, 2019370M+2.4%
Q2 FY2019Jun 30, 2019364M+1.9%
Q1 FY2019Mar 31, 2019361M+3.4%
Q4 FY2018Dec 31, 2018340M-2.3%
Q3 FY2018Sep 30, 2018361M+4.2%
Q2 FY2018Jun 30, 2018358M+2.3%
Q1 FY2018Mar 31, 2018349M+2.5%
Q4 FY2017Dec 31, 2017348M+2.8%
Q3 FY2017Sep 30, 2017347M–
Q2 FY2017Jun 30, 2017350M–
Q1 FY2017Mar 31, 2017341M–
Q4 FY2016Dec 31, 2016338M–

More DexCom figures

See a number that looks wrong?